With more cholera outbreaks overstretching the world’s limited vaccine supply, WHO recommends temporarily suspending the standard two-dose regimen to vaccinate more people. Meanwhile, Africa aims to re-energize its COVID-19 vaccine rollout, despite steady decline in public turnout for vaccination.  A shortage in the global supply of cholera vaccines has forced the World Health Organization to […] Continue reading ->
A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading ->